Fate Therapeutics, Inc. (FATE) Social Stream
FATE THERAPEUTICS INC (FATE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering FATE THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 15 | $145 | $60 | $107.4 | $3.77 | 2748.81% |
| 2021-12-14 | 16 | $145 | $60 | $107.4 | $3.77 | 2748.81% |
| 2021-12-15 | 16 | $145 | $60 | $106.666 | $3.77 | 2729.34% |
| 2022-01-11 | 16 | $135 | $60 | $103.866 | $3.77 | 2655.07% |
| 2022-02-01 | 16 | $135 | $52 | $103.2 | $3.77 | 2637.4% |
| 2022-02-07 | 17 | $135 | $42 | $102 | $3.77 | 2605.57% |
| 2022-02-11 | 16 | $135 | $42 | $98.75 | $3.77 | 2519.36% |
| 2022-03-01 | 15 | $135 | $42 | $98.066 | $3.77 | 2501.22% |
| 2022-03-11 | 15 | $135 | $42 | $95.571 | $3.77 | 2435.04% |
| 2022-03-22 | 15 | $135 | $42 | $94.846 | $3.77 | 2415.81% |
| 2022-04-12 | 15 | $135 | $42 | $95.071 | $3.77 | 2421.78% |
| 2022-04-13 | 15 | $135 | $42 | $91.5 | $3.77 | 2327.06% |
| 2022-04-27 | 15 | $135 | $42 | $88.928 | $3.77 | 2258.83% |
| 2022-05-05 | 15 | $135 | $42 | $86.071 | $3.77 | 2183.05% |
| 2022-05-16 | 15 | $135 | $42 | $83.714 | $3.77 | 2120.53% |
| 2022-05-17 | 15 | $135 | $42 | $84.071 | $3.77 | 2130% |
| 2022-05-23 | 15 | $135 | $42 | $81.071 | $3.77 | 2050.42% |
| 2022-06-06 | 16 | $135 | $28 | $77.533 | $3.77 | 1956.58% |
| 2022-07-12 | 16 | $135 | $28 | $75.733 | $3.77 | 1908.83% |
| 2022-08-04 | 17 | $115 | $28 | $72.133 | $3.77 | 1813.34% |
| 2022-08-13 | 17 | $115 | $28 | $72 | $3.77 | 1809.81% |
| 2022-08-18 | 18 | $115 | $28 | $73.125 | $3.77 | 1839.66% |
| 2022-09-17 | 17 | $115 | $28 | $70.8 | $3.77 | 1777.98% |
| 2022-10-05 | 19 | $115 | $28 | $70.8 | $3.77 | 1777.98% |
| 2022-10-10 | 19 | $115 | $28 | $69 | $3.77 | 1730.24% |
| 2022-11-04 | 19 | $115 | $28 | $65.058 | $3.77 | 1625.68% |
| 2022-11-11 | 19 | $115 | $28 | $62.75 | $3.77 | 1564.46% |
| 2022-11-21 | 19 | $115 | $28 | $63.764 | $3.77 | 1591.35% |
| 2022-11-23 | 19 | $115 | $28 | $63.882 | $3.77 | 1594.48% |
| 2022-12-12 | 19 | $115 | $28 | $62.411 | $3.77 | 1555.46% |
| 2022-12-13 | 19 | $115 | $28 | $62 | $3.77 | 1544.56% |
| 2022-12-15 | 20 | $115 | $10 | $59.111 | $3.77 | 1467.93% |
| 2022-12-20 | 20 | $115 | $10 | $56.705 | $3.77 | 1404.11% |
| 2023-01-05 | 22 | $115 | $10 | $54.444 | $3.77 | 1344.14% |
| 2023-01-06 | 22 | $115 | $5.3 | $35.85 | $3.77 | 850.93% |
| 2023-01-09 | 21 | $115 | $4 | $25.076 | $3.77 | 565.15% |
| 2023-03-01 | 21 | $90 | $4 | $18.723 | $3.77 | 396.63% |
| 2023-03-28 | 21 | $90 | $4 | $14.311 | $3.77 | 279.6% |
| 2023-03-31 | 21 | $90 | $4 | $14.37 | $3.77 | 281.17% |
| 2023-04-05 | 22 | $90 | $4 | $14.238 | $3.77 | 277.67% |
| 2023-05-05 | 22 | $90 | $4 | $14.055 | $3.77 | 272.81% |
| 2023-05-08 | 22 | $90 | $4 | $13.888 | $3.77 | 268.38% |
| 2023-06-06 | 21 | $90 | $4 | $13.058 | $3.77 | 246.37% |
| 2023-08-09 | 21 | $90 | $4 | $13.058 | $3.77 | 246.37% |
| 2023-08-15 | 22 | $90 | $4 | $12.188 | $3.77 | 223.29% |
| 2023-09-20 | 22 | $16 | $4 | $7.611 | $3.77 | 101.88% |
| 2023-09-28 | 21 | $16 | $4 | $7.462 | $3.77 | 97.93% |
| 2023-11-10 | 21 | $16 | $3 | $7.118 | $3.77 | 88.81% |
| 2023-11-13 | 21 | $16 | $2 | $6.911 | $3.77 | 83.32% |
| 2023-11-20 | 21 | $16 | $2 | $6.781 | $3.77 | 79.87% |
| 2023-11-29 | 22 | $16 | $2 | $6.676 | $3.77 | 77.08% |
| 2023-12-14 | 21 | $16 | $2 | $6.468 | $3.77 | 71.56% |
The Trend in the Analyst Price Target
FATE's average price target has moved down $12.25 over the prior 46 weeks.
Over the past 48 weeks, FATE's average upside potential has been 232.56%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-09 | 22 | 115 | 4 | 29.516 | 5.27 | 460.08% |
| 2023-01-09 | 21 | 115 | 4 | 25.076 | 5.27 | 375.83% |
| 2023-01-26 | 21 | 90 | 4 | 18.723 | 5.30 | 253.26% |
| 2023-08-09 | 21 | 90 | 4 | 13.058 | 3.40 | 284.06% |
| 2023-09-28 | 21 | 16 | 4 | 7.462 | 2.18 | 242.29% |
FATE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.57 | 6 | 0 | 13 | 1 | 1 | 21 |
The Trend in the Broker Recommendations
Over the past 16 months, FATE's average broker recommendation rating worsened by 1.1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how FATE THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 6781.83% of that group.
- To contextualize these metrics, consider that out of all US stocks, FATE THERAPEUTICS INC's variance in analysts' estimates is lower than -6615.83% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, FATE THERAPEUTICS INC's number of analysts covering the stock is higher than 7034.48% of them.
- In the context of stocks in the mid market cap category, FATE THERAPEUTICS INC's average analyst price target is greater than 4248.31% of them.
Stocks similar to FATE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NSTG, SGMO, and VCEL.
View All Top Stocks by Price Target
Is FATE a Buy, Hold or Sell? See the POWR Ratings now!